KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Work In Process (2019 - 2025)

Opko Health's Work In Process history spans 7 years, with the latest figure at $726000.0 for Q4 2025.

  • For Q4 2025, Work In Process fell 69.17% year-over-year to $726000.0; the TTM value through Dec 2025 reached $726000.0, down 69.17%, while the annual FY2025 figure was $726000.0, 69.17% down from the prior year.
  • Work In Process reached $726000.0 in Q4 2025 per OPK's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $3.7 million in Q2 2023 to a low of $726000.0 in Q4 2025.
  • Average Work In Process over 5 years is $2.3 million, with a median of $2.4 million recorded in 2022.
  • Peak YoY movement for Work In Process: crashed 69.34% in 2021, then skyrocketed 51.64% in 2022.
  • A 5-year view of Work In Process shows it stood at $1.6 million in 2021, then surged by 51.64% to $2.4 million in 2022, then dropped by 29.32% to $1.7 million in 2023, then soared by 36.05% to $2.4 million in 2024, then tumbled by 69.17% to $726000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPK's Work In Process are $726000.0 (Q4 2025), $2.5 million (Q3 2025), and $2.5 million (Q2 2025).